Sonnet BioTherapeutic News

Sonnet BioTherapeutics Releases Virtual Investor '"What This Means" Segment

GlobeNewswireNov 12 09:15 ET

Sonnet BioTherapeutics Announces Pricing of $5.0 Million Underwritten Public Offering Priced At-The-Market Under Nasdaq Rules

GlobeNewswireNov 6 13:20 ET

Gold Down Over 2%; CVS Health Shares Jump After Q3 Results

BenzingaNov 6 12:47 ET

12 Health Care Stocks Moving In Wednesday's Intraday Session

BenzingaNov 6 11:34 ET

Trending Stocks Today | FOXO Technologies Surges 172.81%

Moomoo NewsNov 6 10:05 ET

Express News | Sonnet BioTherapeutics Shares Resume Trade

BenzingaNov 6 09:42 ET

Express News | Sonnet BioTherapeutics Shares Halted On Circuit Breaker To The Downside, Stock Now Up 106.9%

BenzingaNov 6 09:34 ET

Sonnet BioTherapeutics Announces Issuance Of U.S. Patent Covering A Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

BenzingaNov 6 08:33 ET

Express News | Sonnet Biotherapeutics Holdings Inc - Patent Term Effective Until June 2044

ReutersNov 6 08:30 ET

Sonnet BioTherapeutics Announces Issuance of U.S. Patent Covering a Variant IL-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

GlobeNewswireNov 6 08:30 ET

Express News | Sonnet Biotherapeutics Announces Issuance of U.S. Patent Covering a Variant Il-18 Incorporated Into Two Novel Immunotherapeutic Drug Candidates

ReutersNov 6 08:30 ET

Top Midday Decliners

MT NewswiresOct 28 15:01 ET

Sonnet Stock Tumbles 22% in Wake of Proposed Offering Filing

Seeking AlphaOct 28 12:45 ET

Dow Jumps Over 300 Points; ON Semiconductor Earnings Top Views

BenzingaOct 28 09:59 ET

Sonnet Biotherapeutics Files To Sell Common Stock, Warrants; Terms Not Disclosed

BenzingaOct 28 09:57 ET

12 Health Care Stocks Moving In Thursday's Intraday Session

BenzingaOct 17 12:30 ET

Sonnet BioTherapeutics Inc. Regains Compliance With Nasdaq

Globe NewswireOct 17 08:45 ET

Express News | Sonnet Biotherapeutics Inc. Regains Compliance With Nasdaq

ReutersOct 17 08:45 ET

Express News | Sonnet BioTherapeutics Shares Are Trading Higher After the Company Announced That It Has Entered Into a Licensing Agreement With Alkem Laboratories for the Research, Development, Manufacturing, Marketing and Commercialization of Its Molecule SON-080...

BenzingaOct 9 08:47 ET

Express News | Sonnet Biotherapeutics Holdings Inc - Entitled to Receive Low Double-Digit Royalty on Net Sales of Son-080

ReutersOct 9 08:45 ET